Knockdown of Endogenous Nucb2/Nesfatin-1 in the PVN Leads to Obese-Like Phenotype and Abolishes the Metformin- and Stress-Induced Thermogenic Response in Rats

Abstract

Nesfatin-1, the cleavage product of nucleobindin-2, is an anorexigenic peptide and major regulator of energy homeostasis. Beyond reducing food intake and increasing energy expenditure, it is also involved in regulating the stress response. Interaction of nucleobindin-2/nesfatin-1 and glucose homeostasis has been observed and recent findings suggest a link between the action of the antidiabetic drug metformin and the nesfatinergic system. Hence, this study aimed to clarify the role of nucleobindin-2/nesfatin-1 in the paraventricular nucleus of the hypothalamus in energy homeostasis as well as its involvement in stress- and metformin-mediated changes in energy expenditure. Knockdown of nucleobindin-2/nesfatin-1 in male Wistar rats led to significantly increased food intake, body weight, and reduced energy expenditure compared to controls. Nucleobindin-2/nesfatin-1 knockdown animals developed an obese-like phenotype represented by significantly increased fat mass and overall increase of circulating lipids. Concomitantly, expression of nucleobindin-2 and melanocortin receptor type 3 and 4 mRNA in the paraventricular nucleus was decreased indicating successful knockdown and impairment at the level of the melanocortin system. Additionally, stress induced activation of interscapular brown adipose tissue was significantly decreased in nucleobindin-2/nesfatin-1 knockdown animals and accompanied by lower adrenal weight. Finally, intracerebroventricular administration of metformin significantly increased energy expenditure in controls and this effect was absent in nucleobindin-2/nesfatin-1 knockdown animals. Overall, we clarified the crucial role of nucleobindin-2/nesfatin-1 in the paraventricular nucleus of the hypothalamus in the regulation of energy homeostasis. The nesfatinergic system was further identified as important mediator in stress- and metformin-induced thermogenesis.

Key words

energy homeostasis - obesity  - metabolic syndrome - oral antidiabetic drugs; OAD  - diabetes - hypothalamus - NTS - brown adipose tissue

^* These authors contributed equally.

Publication History

Received: 11 May 2022

Accepted after revision: 11 August 2022

Article published online:
04 October 2022

• References

• 1 Oh-I S, Shimizu H, Satoh T. et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443: 709-712
• 2 Wernecke K, Lamprecht I, Jöhren O. et al. Nesfatin-1 increases energy expenditure and reduces food intake in rats. Obesity 2014; 22: 1662-1668
• 3 Dore R, Levata L, Lehnert H. et al. Nesfatin-1: functions and physiology of a novel regulatory peptide. J Endocrinol 2017; 232: R45-R65
• 4 Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277-359
• 5 Dore R, Levata L, Gachkar S. et al. The thermogenic effect of nesfatin-1 requires recruitment of the melanocortin system. J Endocrinol 2017; 235: 111-122
• 6 Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008; 156: 563-579
• 7 Kohno D, Nakata M, Maejima Y. et al. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 2008; 149: 1295-1301
• 8 Ramanjaneya M, Chen J, Brown JE. et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010; 151: 3169-3180
• 9 Stengel A, Goebel M, Yakubov I. et al. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009; 150: 232-238
• 10 Brailoiu GC, Dun SL, Brailoiu E. et al. Nesfatin-1: Distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007; 148: 5088-5094
• 11 Rupp SK, Wölk E, Stengel A. Nesfatin-1 receptor: distribution, signaling and increasing evidence for a G protein-coupled receptor – a systematic review. Front Endocrinol (Lausanne) 2021; 12: 740174
• 12 Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428
• 13 Liu Y, Chen X, Qu Y. et al. Central nesfatin-1 activates lipid mobilization in adipose tissue and fatty acid oxidation in muscle via the sympathetic nervous system. Biofactors 2020; 46: 454-464
• 14 Chen X, Dong J, Jiang Z-Y. Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake. Regul Pept 2012; 177: 21-26
• 15 Wu D, Yang M, Chen Y. et al. Hypothalamic nesfatin-1/NUCB2 knockdown augments hepatic gluconeogenesis that is correlated with inhibition of mTOR-STAT3 signaling pathway in rats. Diabetes 2014; 63: 1234-1247
• 16 Yang M, Zhang Z, Wang C. et al. Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes 2012; 61: 1959-1968
• 17 Su Y, Zhang J, Tang Y. et al. The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 2010; 391: 1039-1042
• 18 Zhou G, Myers R, Li Y. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174
• 19 Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000; 348: 607-614
• 20 Lee CK, Choi YJ, Park SY. et al. Intracerebroventricular injection of metformin induces anorexia in rats. Diabetes Metab J 2012; 36: 293-299
• 21 Tokubuchi I, Tajiri Y, Iwata S. et al. Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats. PLoS One 2017; 12: e0171293
• 22 Rouquet T, Clément P, Gaigé S. et al. Acute oral metformin enhances satiation and activates brainstem nesfatinergic neurons. Obesity 2014; 22: 2552-2562
• 23 Merali Z, Cayer C, Kent P. et al. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology 2008; 201: 115
• 24 Könczöl K, Bodnár I, Zelena D. et al. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic–pituitary–adrenal axis in rats. Neurochem Int 2010; 57: 189-197
• 25 Goebel M, Stengel A, Wang L. et al. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 2009; 1300: 114-124
• 26 Yoshida N, Maejima Y, Sedbazar U. et al. Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY) 2010; 2: 775-784
• 27 Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sixth Edition. Elsevier: Academic Press; New York: 2006
• 28 Dore R, Iemolo A, Smith KL. et al. CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology 2013; 38: 2160-2169
• 29 Aherrahrou R, Kulle AE, Alenina N. et al. CYP17A1 deficient XY mice display susceptibility to atherosclerosis, altered lipidomic profile and atypical sex development. Sci Rep 2020; 10: 8792
• 30 Karsai G, Kraft F, Haag N. et al. DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans. J Clin Invest 2019; 129: 1229-1239
• 31 Schulz C, Paulus K, Jöhren O. et al. Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO). Endocrinology 2012; 153: 143-153
• 32 Chong J, Soufan O, Li C. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 2018; 46: W486-W494
• 33 Pang Z, Chong J, Zhou G. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 2021; 49: W388-W396
• 34 Darambazar G, Nakata M, Okada T. et al. Paraventricular NUCB2/nesfatin-1 is directly targeted by leptin and mediates its anorexigenic effect. Biochem Biophys Res Commun 2015; 456: 913-918
• 35 Maejima Y, Sedbazar U, Suyama S. et al. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 2009; 10: 355-365
• 36 Dore R, Krotenko R, Reising JP. et al. Nesfatin-1 decreases the motivational and rewarding value of food. Neuropsychopharmacology 2020; 45: 1645-1655
• 37 Wilz A-M, Wernecke K, Appel L. et al. Endogenous NUCB2/nesfatin-1 regulates energy homeostasis under physiological conditions in male rats. Horm Metab Res 2020; 52: 676-684
• 38 Nakata M, Gantulga D, Santoso P. et al. Paraventricular NUCB2/nesfatin-1 supports oxytocin and vasopressin neurons to control feeding behavior and fluid balance in male mice. Endocrinology 2016; 157: 2322-2332
• 39 Levata L, Dore R, Jöhren O. et al. Nesfatin-1 acts centrally to induce sympathetic activation of brown adipose tissue and non-shivering thermogenesis. Horm Metab Res 2019; 51: 678-685
• 40 Aksu O, Aydın B, Doguç DK. et al. The evaluation of nesfatin-1 levels in patients with OSAS associated with metabolic syndrome. J Endocrinol Invest 2015; 38: 463-469
• 41 Gonzalez R, Perry RLS, Gao X. et al. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011; 152: 3628-3637
• 42 Dong J, Xu H, Xu H. et al. Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice. PLoS One 2013; 8: e83397
• 43 Grösch S, Schiffmann S, Geisslinger G. Chain length-specific properties of ceramides. Prog Lipid Res 2012; 51: 50-62
• 44 Gonzalez R, Reingold BK, Gao X. et al. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet □- and MIN6 cells. J Endocrinol 2011; 208: R9-R16
• 45 Li Z, Gao L, Tang H. et al. Peripheral effects of nesfatin-1 on glucose homeostasis. PLoS One 2013; 8: e71513
• 46 Blevins JE, Baskin DG. Hypothalamic-brainstem circuits controlling eating. Forum Nutr 2010; 63: 133-140
• 47 Larsen PJ, Hay-Schmidt A, Mikkelsen JD. Efferent connections from the lateral hypothalamic region and the lateral preoptic area to the hypothalamic paraventricular nucleus of the rat. J Comp Neurol 1994; 342: 299-319
• 48 Bamshad M, Song CK, Bartness TJ. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am J Physiol 1999; 276: R1569-R1578
• 49 Bamshad M, Aoki VT, Adkison MG. et al. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am J Physiol 1998; 275: R291-R299
• 50 Shi Y-C, Lau J, Lin Z. et al. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab 2013; 17: 236-248
• 51 Xu Y-Y, Ge J-F, Qin G. et al. Acute, but not chronic, stress increased the plasma concentration and hypothalamic mRNA expression of NUCB2/nesfatin-1 in rats. Neuropeptides 2015; 54: 47-53
• 52 Ulrich-Lai YM, Figueiredo HF, Ostrander MM. et al. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J PhysiolEndocrinol Metab 2006; 291: E965-E973